Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Abstract 5248: ED-71, an analogue of Vitamin D₃, blocks the promotion but not the initiation of colorectal tumors in the Apc^+/Min-FCCC mouse model

Wen-Chi L. Chang, Harry S. Cooper, Esther Kaunga, Lisa Vanderveer, Jing Peng, Suen S. Chen, Margie L. Clapper

Cancer Res (2016) 76 (14_Supplement): 5248.

https://doi.org/10.1158/1538-7445.AM2016-5248

Published: 15 July 2016

View articletitled, Abstract 5248: ED-71, an analogue of Vitamin D3, blocks the promotion but not the initiation of colorectal tumors in the Apc+/Min-FCCC mouse model

Journal Articles

Abstract 2806: Effect of ED-71, an analogue of Vitamin D3, on intestinal neoplasia in the Apc+/Min-FCCC mouse model

Wen-Chi L. Chang, Esther Kaunga, Harry S. Cooper, Lisa Vanderveer, Jing Peng, Yongchao Zhang, Chen S. Suen, Margie L. Clapper

Cancer Res (2015) 75 (15_Supplement): 2806.

https://doi.org/10.1158/1538-7445.AM2015-2806

Published: 01 August 2015

View articletitled, Abstract 2806: Effect of ED-71, an analogue of Vitamin D3, on intestinal neoplasia in the Apc+/Min-FCCC mouse model

Journal Articles

Abstract LB-090: Estrogen metabolism within the human lung: impact of tumorigenesis, tobacco smoke, gender and race

Jing Peng, Xia Xu, William E. Smith, Sibele I. Meireles, Stacy L. Mosier, Guo Zhang, Shumenghui Zhai, Xiang Ma, Michael J. Slifker, Karthik Devarajan, Mindy S. Kurzer, Grace X. Ma, Margie L. Clapper

Cancer Res (2015) 75 (15_Supplement): LB-090.

https://doi.org/10.1158/1538-7445.AM2015-LB-090

Published: 01 August 2015

View articletitled, Abstract LB-090: Estrogen metabolism within the human lung: impact of tumorigenesis, tobacco smoke, gender and race

Journal Articles

The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation

Debasish Raha, Timothy R. Wilson, Jing Peng, David Peterson, Peng Yue, Marie Evangelista, Catherine Wilson, Mark Merchant, Jeff Settleman

Cancer Res (2014) 74 (13): 3579–3590.

https://doi.org/10.1158/0008-5472.CAN-13-3456

Published: 30 June 2014

View articletitled, The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation

Includes: Supplementary data

Journal Articles

Abstract 2162: Inhibition of pancreatic cancer cell and tumor growth using MET inhibitors in combination with inhibitors of downstream signaling mediators, MEK and PI3K.

Nai-Ying Yang, Jing Peng, Janet Tien, Mark Merchant

Cancer Res (2013) 73 (8_Supplement): 2162.

https://doi.org/10.1158/1538-7445.AM2013-2162

Published: 15 April 2013

View articletitled, Abstract 2162: Inhibition of pancreatic cancer cell and tumor growth using MET inhibitors in combination with inhibitors of downstream signaling mediators, MEK and PI3K.

Journal Articles

Abstract 4816: Tobacco smoke modulates estrogen metabolism in the mouse lung

Jing Peng, Xia Xu, Brian Mace, Lisa Vanderveer, Patrick Sullivan, Margie L. Clapper

Cancer Res (2012) 72 (8_Supplement): 4816.

https://doi.org/10.1158/1538-7445.AM2012-4816

Published: 15 April 2012

View articletitled, Abstract 4816: Tobacco smoke modulates estrogen metabolism in the mouse lung

Journal Articles

Abstract 1203: Therapeutic opportunities for anti-Met antibody (MetMAb) in breast cancer

Merchant Mark, Zhong Zheng, Jing Peng, Jun Li, Elaine Mai, Judy Young, Dela Cruz Darlene, Jinfeng Liu, Robert Yauch, Jiping Zha, Ellen Filvaroff

Cancer Res (2011) 71 (8_Supplement): 1203.

https://doi.org/10.1158/1538-7445.AM2011-1203

Published: 15 April 2011

View articletitled, Abstract 1203: Therapeutic opportunities for anti-Met antibody (MetMAb) in breast cancer

Journal Articles

Abstract #DDT02-2: MCS110: a monoclonal antibody with potent neutralizing activity against macrophage colony-stimulating factor for the treatment of tumor-induced osteolysis

Nancy Pryer, Victoria Sung, Ursula Jeffry, Jing Peng, Yoko Oei, Ying Cao, Arnold Horwitz, Kathleen Meyer, Janet Price, Cheng Liu, Michael Kavanaugh, Judith Abraham

Cancer Res (2009) 69 (9_Supplement): DDT02-2.

Published: 01 May 2009

View articletitled, Abstract #DDT02-2: MCS110: a monoclonal antibody with potent neutralizing activity against macrophage colony-stimulating factor for the treatment of tumor-induced osteolysis

Journal Articles

Abstract #2233: Preclinical evaluation of anti-M-CSF antibodies in mouse models of tumor-induced osteolysis

Nancy Pryer, Victoria Sung, Jing Peng, Yoko Oei, Dylan Daniel, Sharon Aukerman, Li Long, Janet Price, Cheng Liu, Judith Abraham, W. Michael Kavanaugh

Cancer Res (2009) 69 (9_Supplement): 2233.

Published: 01 May 2009

View articletitled, Abstract #2233: Preclinical evaluation of anti-M-CSF antibodies in mouse models of tumor-induced osteolysis

Journal Articles

GPR30 modulates estrogen-stimulated proliferation of breast and endometrial cancer cells by regulating estrogen receptor alpha homeostasis

Eric Ariazi, Heather Shupp, Jing Peng, Anne Donato, Surojeet Sengupta, Catherine Sharma, Helen Kim, Heather Cunliffe, Eric Prossnitz, V. Craig Jordan

Cancer Res (2008) 68 (9_Supplement): 5452.

Published: 01 May 2008

View articletitled, GPR30 modulates estrogen-stimulated proliferation of breast and endometrial cancer cells by regulating estrogen receptor alpha homeostasis

Journal Articles

Multitargeted kinase inhibition and sustained biological effects of CHIR-258 contribute to enhanced preclinical efficacy

Daniel E. Lopes de Menezes, Jing Peng, Evelyn N. Garrett, Yan Tang, Sang H. Lee, Lea Aukerman, Carla Heise

Cancer Res (2005) 65 (9_Supplement): 160.

Published: 01 May 2005

View articletitled, Multitargeted kinase inhibition and sustained biological effects of CHIR-258 contribute to enhanced preclinical efficacy

Journal Articles

Durable in vivo target modulation with CHIR258, a small molecule inhibitor of growth factor tyrosine kinase receptors, is associated with potent antitumor efficacy using various dosing schedules.

Sang Hoon Lee, Daniel Menezes, Jayesh Vora, Helen Ye, Jing Peng, Evelyn Garrett, Cheryl Goldbeck, Lea Aukerman, Carla Heise

Cancer Res (2004) 64 (7_Supplement): 490.

Published: 01 April 2004

View articletitled, Durable in vivo target modulation with CHIR258, a small molecule inhibitor of growth factor tyrosine kinase receptors, is associated with potent antitumor efficacy using various dosing schedules.

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 5248: ED-71, an analogue of Vitamin D₃, blocks the promotion but not the initiation of colorectal tumors in the Apc^+/Min-FCCC mouse model

Abstract 2806: Effect of ED-71, an analogue of Vitamin D3, on intestinal neoplasia in the Apc+/Min-FCCC mouse model

Abstract LB-090: Estrogen metabolism within the human lung: impact of tumorigenesis, tobacco smoke, gender and race

The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation

Abstract 2162: Inhibition of pancreatic cancer cell and tumor growth using MET inhibitors in combination with inhibitors of downstream signaling mediators, MEK and PI3K.

Abstract 4816: Tobacco smoke modulates estrogen metabolism in the mouse lung

Abstract 1203: Therapeutic opportunities for anti-Met antibody (MetMAb) in breast cancer

Abstract #DDT02-2: MCS110: a monoclonal antibody with potent neutralizing activity against macrophage colony-stimulating factor for the treatment of tumor-induced osteolysis

Abstract #2233: Preclinical evaluation of anti-M-CSF antibodies in mouse models of tumor-induced osteolysis

GPR30 modulates estrogen-stimulated proliferation of breast and endometrial cancer cells by regulating estrogen receptor alpha homeostasis

Multitargeted kinase inhibition and sustained biological effects of CHIR-258 contribute to enhanced preclinical efficacy

Durable in vivo target modulation with CHIR258, a small molecule inhibitor of growth factor tyrosine kinase receptors, is associated with potent antitumor efficacy using various dosing schedules.

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only